But there are always moments of great progress and hope. For example, the creation of the Global Fund for AIDS, TB, and ...

Animal rights groups celebrate, but the Trump administration is light on specifics about phasing out federally funded medical ...

Six days after a senior FDA official sent a sweeping internal email claiming that COVID vaccines had caused the deaths of "at ...

After 55 years since it was first considered a Schedule I drug, the Trump Administration is reclassifying marijuana as Schedule III, opening the door for medical research and marijuana as medicine.

Marijuana may soon be rescheduled, and the biggest change could be taxes. Here’s how reclassification could lower tax bills ...

UH and Case Western researchers found income and property ownership, not race, determine who accesses potentially life-saving ...

Priority will be given to community-based, cost-effective research in collaboration with government research institutions, ...

Trump's executive order elevates cannabis research while a new hemp ban looms, easing industry uncertainty and opening doors.

An NIH study was a beacon for the topical steroid withdrawal community. Then, amid federal upheaval, the research stalled.

Michael Pfeffer is CIDO of Stanford Health Care and Associate Dean at the Stanford University School of Medicine, and a ...

Researchers at the Johns Hopkins Kimmel Cancer Center’s Ludwig Center developed a new treatment that selectively targets ...

The Majewski family remains hopeful for their four-year-old son Max, who has a rare neurological disorder, as they seek ...